GSK's CEO is hopeful that a COVID-19 vaccine will be available next year

Pharmaceutical

Emma Walmsley, Chief Executive Officer of GlaxoSmithKline ( GSK), hopes that next year, following the collaboration with Sanofi on the COVID-19 vaccine project, the COVID-19 vaccine will be commonly available to provide an adjuvant to be used with the recombinant protein-based vaccine candidate from Sanofi.

“GSK's CEO is hopeful that a COVID-19 vaccine will be available next year.“

Lately, vaccine developers have been moving at extraordinary speed to develop a successful vaccine targeting SARS-CoV-2. Despite this speed being impressive given the current conditions, experts have raised concerns in regard to ensuring the safety of any potential vaccine.

See all the latest jobs in Pharmaceutical
Return to news